Citation Impact
Citing Papers
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV
2003
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
The global burden of hepatitis C
2009
Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts
2005
Hepatitis C virus: Epidemiology and transmission
1997
Leishmaniasis
2018 Standout
Effect of Highly Active Antiretroviral Therapy on the Incidence and Clinical Manifestations of Visceral Leishmaniasis in Human Immunodeficiency Virus--Infected Patients
2003
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection
1996
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes
2004
Liver fibrosis
2005 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis
2008
Hepatitis C Virus Infection
2001 Standout
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
2001
Leishmaniasis in immunosuppressed individuals
2014
Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: Clinical Management Issues
2000
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
2007
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome
2001
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
The biological diagnosis of leishmaniasis in HIV-infected patients
2003
HIV-Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy
2000
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Antiretroviral Therapy for HIV Infection
1998
Transfusion Medicine — Blood Transfusion
1999 Standout
Effect of Immune Globulin on the Prevention of Experimental Hepatitis C Virus Infection
1996
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
2012
Absence of Hepatitis C Virus and Detection of Hepatitis G Virus/GB Virus C RNA Sequences in the Semen of Infected Men
1998
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection
2006
Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy
2003
The performance of direct agglutination tests (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV co-infection
2002
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
2005
Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus
2003
Treatment of leishmaniasis in HIV-positive patients
2003
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Antiretroviral Drug Resistance: Mechanisms, Pathogenesis, Clinical Significance
1996
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients
2001
Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up
2004
The pathogenesis ofLeishmania/HIV co-infection: cellular and immunological mechanisms
2003
Review: HIV infection and tropical parasitic diseases – deleterious interactions in both directions?
2002
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
2001
Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala‐azar in Sudan
2003
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan
2015
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
2012
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Hepatitis C: Natural History of a Unique Infection
1995
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
2002
To C or not to C: these are the questions
1995
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques
2003 StandoutNobel
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.
1988
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge
2002 StandoutNobel
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Advances in leishmaniasis
2005 Standout
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
Electrochemiluminescence (ECL)
2004 Standout
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
EVALUATION OF A NEW RECOMBINANT K39 RAPID DIAGNOSTIC TEST FOR SUDANESE VISCERAL LEISHMANIASIS
2006
Production of resistant HIV mutants during antiretroviral therapy
2000
The Illusion of Sustainability
2007 StandoutNobel
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation
1998
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
2009
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Neutralizing Antibody Response to Hepatitis C Virus
2011
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Positive Regulation of CXCR4 Expression and Signaling by Interleukin-7 in CD4+Mature Thymocytes Correlates with Their Capacity To Favor Human Immunodeficiency X4 Virus Replication
2003 StandoutNobel
FREQUENCY OF VISCERAL LEISHMANIASIS RELAPSES IN HUMAN IMMUNODEFICIENCY VIRUS–INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
2004
Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding
2000 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Improved Detection of Hepatitis B Virus Surface Antigen by a New Rapid Automated Assay
1999
Antimony Toxicity
2010
Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients
1997 StandoutNobel
Field Evaluation of rK39 Test and Direct Agglutination Test for Diagnosis of Visceral Leishmaniasis in a Population with High Prevalence of Human Immunodeficiency Virus in Ethiopia
2009
Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR
2002 StandoutNobel
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
1997
Works of M. Leal being referenced
Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases
1993
Melatonin biosynthesis in the thymus of humans and rats
2007
A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism
2010
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
1999
Provirus Load Changes in Untreated and Zidovudine-Treated Human Immunodeficiency Virus Type I-Infected Patients
1994
PREVENTION OF POST-TRANSFUSION NON-A, NON-B HEPATITIS BY NON-SPECIFIC IMMUNOGLOBULIN IN HEART SURGERY PATIENTS
1988
Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis C
1995
The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1.
1998
Analysis of quasispecies in the viral 5? untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa
2004
Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity
1993
Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients
2001
Viral Envelope Protein of HTLV-III is the Major Target Antigen for Antibodies in Hemophiliac Patients
1986
[Impact of medical approach on the presentation form of AIDS defined by clinical episodes].
1998
Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection
1998
Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART)
2004
CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients
2000
Efficiency of Drug Resistance Genotypic Tests in Specimens with Low HIV Viral Load
1999